Granisetron
Nausea and Vomiting
Alliance for Clinical Trials in OncologySmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 81/ 100
Competitive context
8 Active assets in the Nausea and Vomiting cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Palonosetron Jiuda Zhao | Phase 3 | BB |
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]- Jiuda Zhao | Phase 3 | BB |
Zofran Jiuda Zhao | Phase 3 | BB |
DEXAMETHASONE Jiuda Zhao | Phase 3 | BB |
Hydrodolasetron Gary Morrow | Phase 3 | BB |
View all 24 →
Same molecule, other indications
Granisetron is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →